Flatrock Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$965K Buy
834
+18
+2% +$21.2K 0.33% 50
2026
Q2
$978K Buy
816
+76
+10% +$77.7K 0.38% 45
2026
Q1
$681K Sell
740
-4
-0.5% -$4.06K 0.31% 50
2025
Q4
$799K Buy
+744
New +$711K 0.38% 46

Other funds holding LLY

Flatrock Wealth Partners's LLY Position: Q3 2026 in Review

Flatrock Wealth Partners increased its Eli Lilly (LLY) stake by 2.2% in Q3 2026, buying an estimated $21.2K and bringing the position to 834 shares worth $965K. The position accounts for 0.33% of the portfolio, ranked #50.

Flatrock Wealth Partners first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $978K in Q2 2026. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Flatrock Wealth Partners held 834 shares of Eli Lilly worth $965K as of Q3 2026.
  • Flatrock Wealth Partners bought 18 Eli Lilly shares in Q3 2026, an estimated $21.2K.
  • Eli Lilly made up 0.33% of Flatrock Wealth Partners's portfolio in Q3 2026, its #50 holding.
  • Flatrock Wealth Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Flatrock Wealth Partners's Eli Lilly position peaked at $978K in Q2 2026.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Flatrock Wealth Partners's 13F filing for Q3 2026, filed 12 Nov 2026.